{"gene":"MREG","run_date":"2026-06-10T02:59:51","timeline":{"discoveries":[{"year":1988,"finding":"The murine dilute suppressor gene dsu (encoding MREG) suppresses the coat-color dilution of dilute (d), ashen (ash), and leaden (ln) mutations by restoring normal dendritic melanocyte morphology, acting as a semidominantly inherited trans-acting suppressor unlinked to the d, ash, or ln loci.","method":"Genetic mapping and histological examination of melanocyte morphology in compound mutant mice","journal":"Genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic epistasis confirmed across multiple alleles and loci, replicated across two independent papers from the same lab with morphological readout","pmids":["3410303","3141922"],"is_preprint":false},{"year":1988,"finding":"dsu/MREG does not function like retrotransposon-insertion suppressors in yeast/Drosophila; it suppresses a deletion allele (dl20J) of dilute, indicating a distinct mechanism of suppressor action, and is semidominantly inherited.","method":"Genetic complementation and coat-color suppression testing with a defined deletion allele","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — clean genetic epistasis using a molecularly characterized deletion allele, single lab, two orthogonal genetic tests","pmids":["3141922"],"is_preprint":false},{"year":1990,"finding":"dsu/MREG suppression is specific to coat-color mutations that result from abnormal melanocyte morphology (d, ln, ash, ruby-eye, ruby-eye-2); it does not suppress mutations acting through other pigmentation mechanisms, indicating pathway-specific action on neural crest-derived melanocytes.","method":"Genetic epistasis testing with 14 additional coat-color mutations across 11 loci in mice","journal":"Genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — comprehensive genetic epistasis screen across multiple loci, strong specificity control, replicated phenotypic readout with histology","pmids":["2379821"],"is_preprint":false},{"year":2004,"finding":"dsu is caused by a loss-of-function mutation in a unique vertebrate-specific protein (MREG/melanoregulin) that functions in an MYO5A-independent pathway to alter pigment incorporation into the hair. MYO5A is nonessential for melanosome transfer to keratinocytes, though it is required for peripheral melanosome accumulation in melanocytes.","method":"Positional cloning of dsu locus; genetic and cell biological analysis of MYO5A-deficient mice; complementation and coat-color suppression assays","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — positional cloning identified the gene, genetic epistasis established MYO5A-independence, replicated across multiple mutant backgrounds","pmids":["15550542"],"is_preprint":false},{"year":2009,"finding":"MREG is required for lysosome-dependent phagosome degradation in retinal pigment epithelial (RPE) cells; loss of MREG results in phagosome accumulation (delayed degradation), accumulation of lipofuscin component A2E over time, and defective processing/diminished activity of lysosomal hydrolase cathepsin D.","method":"Mreg−/− mouse phenotypic analysis; cathepsin D activity assay in MREG-deficient human and mouse RPE cells; A2E quantification","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — loss-of-function mouse model with defined cellular phenotypes, enzymatic activity assay, orthogonal biochemical and cell biological readouts","pmids":["19240024"],"is_preprint":false},{"year":2009,"finding":"MREG localizes to small intracellular vesicles in RPE cells and associates with the endosomal phosphoinositide phosphatidylinositol 3,5-bisphosphate (PI(3,5)P2), consistent with a role in intracellular trafficking and lysosome maturation.","method":"Subcellular fractionation, vesicle localization imaging, and phosphoinositide binding assay","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — localization and lipid-binding data from a single lab, two orthogonal methods (imaging + binding assay), functional context provided","pmids":["19240024"],"is_preprint":false},{"year":2012,"finding":"MREG interacts with members of the HPS BLOC-2 complex and with Oa1 (ocular albinism type 1 receptor) to regulate melanosome size; loss of MREG function increases the size of micromelanosomes in BLOC-2 mutant choroid, while transgenic overexpression of MREG corrects the macromelanosome size defect in Oa1 knockout RPE. This provides the first mechanistic link between the BLOC pathway and Oa1 in melanosome biogenesis.","method":"Genetic epistasis using Mreg knockout and MREG transgenic mice crossed with BLOC-2 mutants (ruby, ruby2, cocoa) and Oa1 knockout; immunohistochemical localization of MREG; melanosome size quantification","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic epistasis across multiple mutant backgrounds, transgenic rescue, immunolocalization, quantitative melanosome phenotype readouts in a single rigorous study","pmids":["22984402"],"is_preprint":false},{"year":2012,"finding":"MREG localizes not to melanosomes themselves but to small vesicles in the cytoplasm of RPE cells, consistent with a role in regulating membrane interactions during melanosome biogenesis rather than direct melanosome association.","method":"Immunohistochemical analysis of RPE cell ultrastructure in Mreg transgenic and knockout mice","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — immunolocalization in a single study with genetic validation context, single lab","pmids":["22984402"],"is_preprint":false},{"year":2013,"finding":"Loss of MREG enhances secretion of intermediate cathepsin D (48 kDa) from RPE cells, resulting in increased extracellular cathepsin D activity; MREG is required to maintain intracellular cathepsin D homeostasis. Loss of Mreg(dsu) allele also leads to increased basal laminin accumulation in the RPE.","method":"Cathepsin D secretion and activity assay in Mreg(dsu/dsu) mouse RPE; Western blot for cathepsin D isoforms; laminin immunostaining","journal":"Visual neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — defined loss-of-function mouse model with enzymatic activity readout, single lab, two orthogonal biochemical assays","pmids":["23611523"],"is_preprint":false},{"year":2017,"finding":"MREG overexpression decreases phosphorylation of Akt and mTOR in thyroid cancer cells, suppressing their invasion and proliferation; MREG knockdown has the opposite effect. The mTOR inhibitor dactolisib abrogates the pro-invasive/proliferative effect of MREG knockdown, placing MREG upstream of PI3K/Akt-mTOR signaling.","method":"MREG overexpression and knockdown in thyroid cancer cell lines; Western blot for phospho-Akt and phospho-mTOR; invasion and proliferation assays; pharmacological rescue with dactolisib","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — gain- and loss-of-function with pharmacological rescue, single lab, multiple orthogonal readouts (signaling + functional assays)","pmids":["28698135"],"is_preprint":false},{"year":2022,"finding":"MREG is a direct target of miR-224-5p in hepatocellular carcinoma cells; overexpression of MREG attenuates liver cancer cell migration, invasion, and epithelial-mesenchymal transition (EMT). The E2F1/miR-224-5p axis suppresses MREG to promote these malignant behaviors.","method":"Luciferase reporter or bioinformatic target validation (TargetScan, miRDB, StarBase); MREG overexpression in HCC cell lines; migration/invasion assays; EMT marker analysis; rescue experiments","journal":"Oncology letters","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — direct target validation by database + functional rescue, single lab, multiple cellular readouts; abstract does not specify direct luciferase validation","pmids":["35126724"],"is_preprint":false}],"current_model":"MREG (melanoregulin/dsu) is a vertebrate-specific small charged protein that localizes to small intracellular vesicles and acts in an MYO5A-independent pathway to regulate melanosome biogenesis (interacting with HPS BLOC-2 complex members and the Oa1 receptor to control melanosome size), lysosome maturation and phagosome degradation in retinal pigment epithelial cells (required for cathepsin D processing and activity), and upstream suppression of PI3K/Akt-mTOR signaling in cancer cells; its loss-of-function restores dendritic melanocyte morphology and alters pigment incorporation in hair."},"narrative":{"mechanistic_narrative":"MREG (melanoregulin), encoded by the murine dilute suppressor (dsu) locus, is a vertebrate-specific small protein that regulates vesicular trafficking events underlying melanosome biogenesis and lysosomal maturation [PMID:3410303, PMID:3141922, PMID:19240024]. Originally identified genetically, loss-of-function dsu mutation suppresses the coat-color dilution of dilute, ashen, and leaden by restoring normal dendritic melanocyte morphology, acting as a trans-acting suppressor specific to melanocyte-morphology-based pigmentation mutations [PMID:3410303, PMID:3141922, PMID:2379821]; positional cloning showed it functions in an MYO5A-independent pathway to control pigment incorporation into hair [PMID:15550542]. In retinal pigment epithelium, MREG localizes to small intracellular vesicles, associates with the endosomal phosphoinositide PI(3,5)P2, and is required for lysosome-dependent phagosome degradation, cathepsin D processing and activity, and intracellular cathepsin D homeostasis; its loss causes phagosome and A2E lipofuscin accumulation [PMID:19240024, PMID:23611523]. MREG interacts with HPS BLOC-2 complex members and the Oa1 receptor to control melanosome size, providing a mechanistic link between the BLOC pathway and Oa1, where it acts from cytoplasmic vesicles rather than from melanosomes themselves [PMID:22984402]. In cancer cells, MREG suppresses malignant behavior by acting upstream of PI3K/Akt-mTOR signaling, reducing Akt and mTOR phosphorylation, invasion and proliferation [PMID:28698135], and is silenced by the E2F1/miR-224-5p axis to promote migration, invasion and EMT [PMID:35126724].","teleology":[{"year":1988,"claim":"Established that a distinct trans-acting locus (dsu) could genetically rescue melanocyte-morphology defects caused by mutations at unlinked pigmentation loci, defining MREG as a suppressor of the dilute pathway.","evidence":"Genetic mapping and histological melanocyte morphology analysis in compound mutant mice, including suppression of a defined dilute deletion allele","pmids":["3410303","3141922"],"confidence":"High","gaps":["Molecular identity of the dsu gene product unknown at this stage","Biochemical mechanism of suppression undefined"]},{"year":1990,"claim":"Defined the specificity of MREG action by showing it suppresses only pigmentation mutations arising from abnormal melanocyte morphology, distinguishing a single coherent trafficking pathway from other pigmentation mechanisms.","evidence":"Genetic epistasis testing across 14 additional coat-color mutations spanning 11 loci in mice","pmids":["2379821"],"confidence":"High","gaps":["Did not identify the gene or protein","Molecular pathway components unknown"]},{"year":2004,"claim":"Identified the dsu gene as MREG, a vertebrate-specific protein, and placed it in an MYO5A-independent pathway controlling pigment incorporation into hair, resolving the long-standing molecular identity of the suppressor.","evidence":"Positional cloning of the dsu locus combined with genetic epistasis and complementation in MYO5A-deficient and suppressor mouse backgrounds","pmids":["15550542"],"confidence":"High","gaps":["Direct molecular partners of MREG not identified","Biochemical activity of the protein undefined"]},{"year":2009,"claim":"Extended MREG function beyond pigmentation by showing it is required for lysosome-dependent phagosome degradation and cathepsin D maturation in RPE, linking the protein to vesicular trafficking and lysosome maturation.","evidence":"Mreg-/- mouse phenotyping, cathepsin D activity assays in human and mouse RPE, A2E quantification, vesicle localization and PI(3,5)P2 binding assays","pmids":["19240024"],"confidence":"High","gaps":["Mechanism by which MREG promotes cathepsin D processing unresolved","Direct effector of PI(3,5)P2 binding not defined"]},{"year":2012,"claim":"Provided a mechanistic link in melanosome biogenesis by showing MREG interacts with HPS BLOC-2 members and the Oa1 receptor to control melanosome size, acting from cytoplasmic vesicles rather than melanosomes.","evidence":"Genetic epistasis with Mreg knockout/transgenic mice crossed into BLOC-2 mutant and Oa1 knockout backgrounds, transgenic rescue, immunolocalization, and melanosome size quantification","pmids":["22984402"],"confidence":"High","gaps":["Biochemical nature and stoichiometry of the BLOC-2 and Oa1 interactions not characterized","Whether interactions are direct unresolved"]},{"year":2013,"claim":"Refined the lysosomal role by showing MREG loss enhances secretion of intermediate cathepsin D and disrupts intracellular cathepsin D homeostasis, with concomitant basal laminin accumulation.","evidence":"Cathepsin D secretion/activity assays, Western blot for cathepsin D isoforms, and laminin immunostaining in Mreg(dsu/dsu) mouse RPE","pmids":["23611523"],"confidence":"Medium","gaps":["Mechanistic basis for mis-secretion versus retention unclear","Causal relationship to laminin accumulation not established"]},{"year":2017,"claim":"Implicated MREG as a regulator of growth signaling by placing it upstream of PI3K/Akt-mTOR, where it suppresses cancer cell invasion and proliferation.","evidence":"MREG overexpression and knockdown in thyroid cancer cell lines with phospho-Akt/mTOR Western blots, invasion/proliferation assays, and pharmacological rescue with dactolisib","pmids":["28698135"],"confidence":"Medium","gaps":["Molecular link between MREG and PI3K/Akt-mTOR not defined","Whether this connects to the vesicular trafficking role unknown"]},{"year":2022,"claim":"Positioned MREG within a transcriptional/microRNA regulatory axis, showing it is suppressed by E2F1/miR-224-5p and its restoration attenuates migration, invasion and EMT in hepatocellular carcinoma.","evidence":"miRNA target validation (TargetScan/miRDB/StarBase), MREG overexpression in HCC cell lines, migration/invasion assays, EMT marker analysis, and rescue experiments","pmids":["35126724"],"confidence":"Medium","gaps":["Direct luciferase confirmation of binding not specified","Downstream effectors mediating EMT suppression not identified"]},{"year":null,"claim":"The biochemical activity of MREG and how a single small vesicular protein mechanistically couples melanosome biogenesis, lysosomal cathepsin D maturation, and PI3K/Akt-mTOR signaling remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No defined enzymatic or structural mechanism for the protein","No unifying molecular model linking trafficking and growth-signaling roles","Direct versus indirect nature of reported partner interactions not established"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0008289","term_label":"lipid binding","supporting_discovery_ids":[5]}],"localization":[{"term_id":"GO:0031410","term_label":"cytoplasmic vesicle","supporting_discovery_ids":[5,7]},{"term_id":"GO:0005768","term_label":"endosome","supporting_discovery_ids":[5]}],"pathway":[{"term_id":"R-HSA-9609507","term_label":"Protein localization","supporting_discovery_ids":[4,6]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[9]}],"complexes":[],"partners":["OA1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q8N565","full_name":"Melanoregulin","aliases":["Dilute suppressor protein homolog"],"length_aa":214,"mass_kda":24.9,"function":"Probably functions as a cargo-recognition protein that couples cytoplasmic vesicles to the transport machinery. Plays a role in hair pigmentation, a process that involves shedding of melanosome-containing vesicles from melanocytes, followed by phagocytosis of the melanosome-containing vesicles by keratinocytes. Functions on melanosomes as receptor for RILP and the complex formed by RILP and DCTN1, and thereby contributes to retrograde melanosome transport from the cell periphery to the center. Overexpression causes accumulation of late endosomes and/or lysosomes at the microtubule organising center (MTOC) at the center of the cell. Probably binds cholesterol and requires the presence of cholesterol in membranes to function in microtubule-mediated retrograde organelle transport. Binds phosphatidylinositol 3-phosphate, phosphatidylinositol 4-phosphate, phosphatidylinositol 5-phosphate and phosphatidylinositol 3,5-bisphosphate, but not phosphatidylinositol 3,4-bisphosphate or phosphatidylinositol 4,5-bisphosphate (By similarity). Required for normal phagosome clearing and normal activation of lysosomal enzymes in lysosomes from retinal pigment epithelium cells (PubMed:19240024). Required for normal degradation of the lipofuscin component N-retinylidene-N-retinylethanolamine (A2E) in the eye. May function in membrane fusion and regulate the biogenesis of disk membranes of photoreceptor rod cells (By similarity)","subcellular_location":"Apical cell membrane; Melanosome membrane; Lysosome membrane; Cytoplasmic vesicle membrane","url":"https://www.uniprot.org/uniprotkb/Q8N565/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/MREG","classification":"Not Classified","n_dependent_lines":6,"n_total_lines":1208,"dependency_fraction":0.004966887417218543},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/MREG","total_profiled":1310},"omim":[{"mim_id":"609207","title":"MELANOREGULIN; MREG","url":"https://www.omim.org/entry/609207"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Vesicles","reliability":"Approved"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"retina","ntpm":43.4}],"url":"https://www.proteinatlas.org/search/MREG"},"hgnc":{"alias_symbol":["FLJ10116","DSU","WDT2"],"prev_symbol":[]},"alphafold":{"accession":"Q8N565","domains":[{"cath_id":"1.10.132","chopping":"62-193","consensus_level":"medium","plddt":86.7256,"start":62,"end":193}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q8N565","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q8N565-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q8N565-F1-predicted_aligned_error_v6.png","plddt_mean":71.94},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=MREG","jax_strain_url":"https://www.jax.org/strain/search?query=MREG"},"sequence":{"accession":"Q8N565","fasta_url":"https://rest.uniprot.org/uniprotkb/Q8N565.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q8N565/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q8N565"}},"corpus_meta":[{"pmid":"3410303","id":"PMC_3410303","title":"The murine dilute suppressor gene dsu suppresses the coat-color phenotype of three pigment mutations that alter melanocyte morphology, d, ash and ln.","date":"1988","source":"Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/3410303","citation_count":56,"is_preprint":false},{"pmid":"15550542","id":"PMC_15550542","title":"dsu functions in a MYO5A-independent pathway to suppress the coat color of dilute mice.","date":"2004","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/15550542","citation_count":42,"is_preprint":false},{"pmid":"19240024","id":"PMC_19240024","title":"Melanoregulin (MREG) modulates lysosome function in pigment epithelial cells.","date":"2009","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19240024","citation_count":41,"is_preprint":false},{"pmid":"3141922","id":"PMC_3141922","title":"Dilute suppressor dsu acts semidominantly to suppress the coat color phenotype of a deletion mutation, dl20J, of the murine dilute locus.","date":"1988","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/3141922","citation_count":32,"is_preprint":false},{"pmid":"2379821","id":"PMC_2379821","title":"Interaction of the murine dilute suppressor gene (dsu) with fourteen coat color mutations.","date":"1990","source":"Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/2379821","citation_count":25,"is_preprint":false},{"pmid":"31341483","id":"PMC_31341483","title":"Characterization of the Angiogenic Potential of Human Regulatory Macrophages (Mreg) after Ischemia/Reperfusion Injury In Vitro.","date":"2019","source":"Stem cells international","url":"https://pubmed.ncbi.nlm.nih.gov/31341483","citation_count":16,"is_preprint":false},{"pmid":"28698135","id":"PMC_28698135","title":"MREG suppresses thyroid cancer cell invasion and proliferation by inhibiting Akt-mTOR signaling.","date":"2017","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/28698135","citation_count":15,"is_preprint":false},{"pmid":"35126724","id":"PMC_35126724","title":"E2F1-induced microRNA-224-5p expression is associated with hepatocellular carcinoma cell migration, invasion and epithelial-mesenchymal transition via MREG.","date":"2022","source":"Oncology letters","url":"https://pubmed.ncbi.nlm.nih.gov/35126724","citation_count":13,"is_preprint":false},{"pmid":"37725101","id":"PMC_37725101","title":"Large extracellular vesicles derived from human regulatory macrophages (L-EVMreg) attenuate CD3/CD28-induced T-cell activation in vitro.","date":"2023","source":"Journal of molecular medicine (Berlin, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/37725101","citation_count":9,"is_preprint":false},{"pmid":"22984402","id":"PMC_22984402","title":"Melanoregulin, product of the dsu locus, links the BLOC-pathway and OA1 in organelle biogenesis.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22984402","citation_count":9,"is_preprint":false},{"pmid":"23611523","id":"PMC_23611523","title":"Loss of melanoregulin (MREG) enhances cathepsin-D secretion by the retinal pigment epithelium.","date":"2013","source":"Visual neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/23611523","citation_count":9,"is_preprint":false},{"pmid":"36717876","id":"PMC_36717876","title":"Characterization of large extracellular vesicles (L-EV) derived from human regulatory macrophages (Mreg): novel mediators in wound healing and angiogenesis?","date":"2023","source":"Journal of translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/36717876","citation_count":8,"is_preprint":false},{"pmid":"38835045","id":"PMC_38835045","title":"Effects of temporal IFNγ exposure on macrophage phenotype and secretory profile: exploring GMP-Compliant production of a novel subtype of regulatory macrophages (MregIFNγ0) for potential cell therapeutic applications.","date":"2024","source":"Journal of translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/38835045","citation_count":5,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.02.26.640409","title":"Reduced harmonic complexity of brain parenchymal cardiovascular pulse waveforms in Alzheimer’s disease","date":"2025-03-02","source":"bioRxiv","url":"https://doi.org/10.1101/2025.02.26.640409","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.01.09.632145","title":"Sleep increases propagation speed of physiological brain pulsations","date":"2025-01-12","source":"bioRxiv","url":"https://doi.org/10.1101/2025.01.09.632145","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.01.27.635032","title":"Arousal State Control of Physiological Human Brain Pulsations","date":"2025-01-28","source":"bioRxiv","url":"https://doi.org/10.1101/2025.01.27.635032","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.07.17.600758","title":"Distinct tissue-niche localization and function of synovial tissue myeloid DC subsets in health, and in active and remission Rheumatoid Arthritis","date":"2024-07-19","source":"bioRxiv","url":"https://doi.org/10.1101/2024.07.17.600758","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":11817,"output_tokens":2725,"usd":0.038163,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":9986,"output_tokens":3003,"usd":0.062503,"stage2_stop_reason":"end_turn"},"total_usd":0.100666,"stage1_batch_id":"msgbatch_01BbTCMyrRPyhtEq6b1MdwCN","stage2_batch_id":"msgbatch_011dEed5bbxYvTAaQWKJevxu","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1988,\n      \"finding\": \"The murine dilute suppressor gene dsu (encoding MREG) suppresses the coat-color dilution of dilute (d), ashen (ash), and leaden (ln) mutations by restoring normal dendritic melanocyte morphology, acting as a semidominantly inherited trans-acting suppressor unlinked to the d, ash, or ln loci.\",\n      \"method\": \"Genetic mapping and histological examination of melanocyte morphology in compound mutant mice\",\n      \"journal\": \"Genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic epistasis confirmed across multiple alleles and loci, replicated across two independent papers from the same lab with morphological readout\",\n      \"pmids\": [\"3410303\", \"3141922\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1988,\n      \"finding\": \"dsu/MREG does not function like retrotransposon-insertion suppressors in yeast/Drosophila; it suppresses a deletion allele (dl20J) of dilute, indicating a distinct mechanism of suppressor action, and is semidominantly inherited.\",\n      \"method\": \"Genetic complementation and coat-color suppression testing with a defined deletion allele\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean genetic epistasis using a molecularly characterized deletion allele, single lab, two orthogonal genetic tests\",\n      \"pmids\": [\"3141922\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1990,\n      \"finding\": \"dsu/MREG suppression is specific to coat-color mutations that result from abnormal melanocyte morphology (d, ln, ash, ruby-eye, ruby-eye-2); it does not suppress mutations acting through other pigmentation mechanisms, indicating pathway-specific action on neural crest-derived melanocytes.\",\n      \"method\": \"Genetic epistasis testing with 14 additional coat-color mutations across 11 loci in mice\",\n      \"journal\": \"Genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — comprehensive genetic epistasis screen across multiple loci, strong specificity control, replicated phenotypic readout with histology\",\n      \"pmids\": [\"2379821\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"dsu is caused by a loss-of-function mutation in a unique vertebrate-specific protein (MREG/melanoregulin) that functions in an MYO5A-independent pathway to alter pigment incorporation into the hair. MYO5A is nonessential for melanosome transfer to keratinocytes, though it is required for peripheral melanosome accumulation in melanocytes.\",\n      \"method\": \"Positional cloning of dsu locus; genetic and cell biological analysis of MYO5A-deficient mice; complementation and coat-color suppression assays\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — positional cloning identified the gene, genetic epistasis established MYO5A-independence, replicated across multiple mutant backgrounds\",\n      \"pmids\": [\"15550542\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"MREG is required for lysosome-dependent phagosome degradation in retinal pigment epithelial (RPE) cells; loss of MREG results in phagosome accumulation (delayed degradation), accumulation of lipofuscin component A2E over time, and defective processing/diminished activity of lysosomal hydrolase cathepsin D.\",\n      \"method\": \"Mreg−/− mouse phenotypic analysis; cathepsin D activity assay in MREG-deficient human and mouse RPE cells; A2E quantification\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — loss-of-function mouse model with defined cellular phenotypes, enzymatic activity assay, orthogonal biochemical and cell biological readouts\",\n      \"pmids\": [\"19240024\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"MREG localizes to small intracellular vesicles in RPE cells and associates with the endosomal phosphoinositide phosphatidylinositol 3,5-bisphosphate (PI(3,5)P2), consistent with a role in intracellular trafficking and lysosome maturation.\",\n      \"method\": \"Subcellular fractionation, vesicle localization imaging, and phosphoinositide binding assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — localization and lipid-binding data from a single lab, two orthogonal methods (imaging + binding assay), functional context provided\",\n      \"pmids\": [\"19240024\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"MREG interacts with members of the HPS BLOC-2 complex and with Oa1 (ocular albinism type 1 receptor) to regulate melanosome size; loss of MREG function increases the size of micromelanosomes in BLOC-2 mutant choroid, while transgenic overexpression of MREG corrects the macromelanosome size defect in Oa1 knockout RPE. This provides the first mechanistic link between the BLOC pathway and Oa1 in melanosome biogenesis.\",\n      \"method\": \"Genetic epistasis using Mreg knockout and MREG transgenic mice crossed with BLOC-2 mutants (ruby, ruby2, cocoa) and Oa1 knockout; immunohistochemical localization of MREG; melanosome size quantification\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic epistasis across multiple mutant backgrounds, transgenic rescue, immunolocalization, quantitative melanosome phenotype readouts in a single rigorous study\",\n      \"pmids\": [\"22984402\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"MREG localizes not to melanosomes themselves but to small vesicles in the cytoplasm of RPE cells, consistent with a role in regulating membrane interactions during melanosome biogenesis rather than direct melanosome association.\",\n      \"method\": \"Immunohistochemical analysis of RPE cell ultrastructure in Mreg transgenic and knockout mice\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — immunolocalization in a single study with genetic validation context, single lab\",\n      \"pmids\": [\"22984402\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Loss of MREG enhances secretion of intermediate cathepsin D (48 kDa) from RPE cells, resulting in increased extracellular cathepsin D activity; MREG is required to maintain intracellular cathepsin D homeostasis. Loss of Mreg(dsu) allele also leads to increased basal laminin accumulation in the RPE.\",\n      \"method\": \"Cathepsin D secretion and activity assay in Mreg(dsu/dsu) mouse RPE; Western blot for cathepsin D isoforms; laminin immunostaining\",\n      \"journal\": \"Visual neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — defined loss-of-function mouse model with enzymatic activity readout, single lab, two orthogonal biochemical assays\",\n      \"pmids\": [\"23611523\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"MREG overexpression decreases phosphorylation of Akt and mTOR in thyroid cancer cells, suppressing their invasion and proliferation; MREG knockdown has the opposite effect. The mTOR inhibitor dactolisib abrogates the pro-invasive/proliferative effect of MREG knockdown, placing MREG upstream of PI3K/Akt-mTOR signaling.\",\n      \"method\": \"MREG overexpression and knockdown in thyroid cancer cell lines; Western blot for phospho-Akt and phospho-mTOR; invasion and proliferation assays; pharmacological rescue with dactolisib\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — gain- and loss-of-function with pharmacological rescue, single lab, multiple orthogonal readouts (signaling + functional assays)\",\n      \"pmids\": [\"28698135\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"MREG is a direct target of miR-224-5p in hepatocellular carcinoma cells; overexpression of MREG attenuates liver cancer cell migration, invasion, and epithelial-mesenchymal transition (EMT). The E2F1/miR-224-5p axis suppresses MREG to promote these malignant behaviors.\",\n      \"method\": \"Luciferase reporter or bioinformatic target validation (TargetScan, miRDB, StarBase); MREG overexpression in HCC cell lines; migration/invasion assays; EMT marker analysis; rescue experiments\",\n      \"journal\": \"Oncology letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — direct target validation by database + functional rescue, single lab, multiple cellular readouts; abstract does not specify direct luciferase validation\",\n      \"pmids\": [\"35126724\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"MREG (melanoregulin/dsu) is a vertebrate-specific small charged protein that localizes to small intracellular vesicles and acts in an MYO5A-independent pathway to regulate melanosome biogenesis (interacting with HPS BLOC-2 complex members and the Oa1 receptor to control melanosome size), lysosome maturation and phagosome degradation in retinal pigment epithelial cells (required for cathepsin D processing and activity), and upstream suppression of PI3K/Akt-mTOR signaling in cancer cells; its loss-of-function restores dendritic melanocyte morphology and alters pigment incorporation in hair.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"MREG (melanoregulin), encoded by the murine dilute suppressor (dsu) locus, is a vertebrate-specific small protein that regulates vesicular trafficking events underlying melanosome biogenesis and lysosomal maturation [#0, #4]. Originally identified genetically, loss-of-function dsu mutation suppresses the coat-color dilution of dilute, ashen, and leaden by restoring normal dendritic melanocyte morphology, acting as a trans-acting suppressor specific to melanocyte-morphology-based pigmentation mutations [#0, #2]; positional cloning showed it functions in an MYO5A-independent pathway to control pigment incorporation into hair [#3]. In retinal pigment epithelium, MREG localizes to small intracellular vesicles, associates with the endosomal phosphoinositide PI(3,5)P2, and is required for lysosome-dependent phagosome degradation, cathepsin D processing and activity, and intracellular cathepsin D homeostasis; its loss causes phagosome and A2E lipofuscin accumulation [#4, #5, #8]. MREG interacts with HPS BLOC-2 complex members and the Oa1 receptor to control melanosome size, providing a mechanistic link between the BLOC pathway and Oa1, where it acts from cytoplasmic vesicles rather than from melanosomes themselves [#6, #7]. In cancer cells, MREG suppresses malignant behavior by acting upstream of PI3K/Akt-mTOR signaling, reducing Akt and mTOR phosphorylation, invasion and proliferation [#9], and is silenced by the E2F1/miR-224-5p axis to promote migration, invasion and EMT [#10].\",\n  \"teleology\": [\n    {\n      \"year\": 1988,\n      \"claim\": \"Established that a distinct trans-acting locus (dsu) could genetically rescue melanocyte-morphology defects caused by mutations at unlinked pigmentation loci, defining MREG as a suppressor of the dilute pathway.\",\n      \"evidence\": \"Genetic mapping and histological melanocyte morphology analysis in compound mutant mice, including suppression of a defined dilute deletion allele\",\n      \"pmids\": [\"3410303\", \"3141922\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular identity of the dsu gene product unknown at this stage\", \"Biochemical mechanism of suppression undefined\"]\n    },\n    {\n      \"year\": 1990,\n      \"claim\": \"Defined the specificity of MREG action by showing it suppresses only pigmentation mutations arising from abnormal melanocyte morphology, distinguishing a single coherent trafficking pathway from other pigmentation mechanisms.\",\n      \"evidence\": \"Genetic epistasis testing across 14 additional coat-color mutations spanning 11 loci in mice\",\n      \"pmids\": [\"2379821\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not identify the gene or protein\", \"Molecular pathway components unknown\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Identified the dsu gene as MREG, a vertebrate-specific protein, and placed it in an MYO5A-independent pathway controlling pigment incorporation into hair, resolving the long-standing molecular identity of the suppressor.\",\n      \"evidence\": \"Positional cloning of the dsu locus combined with genetic epistasis and complementation in MYO5A-deficient and suppressor mouse backgrounds\",\n      \"pmids\": [\"15550542\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct molecular partners of MREG not identified\", \"Biochemical activity of the protein undefined\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Extended MREG function beyond pigmentation by showing it is required for lysosome-dependent phagosome degradation and cathepsin D maturation in RPE, linking the protein to vesicular trafficking and lysosome maturation.\",\n      \"evidence\": \"Mreg-/- mouse phenotyping, cathepsin D activity assays in human and mouse RPE, A2E quantification, vesicle localization and PI(3,5)P2 binding assays\",\n      \"pmids\": [\"19240024\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism by which MREG promotes cathepsin D processing unresolved\", \"Direct effector of PI(3,5)P2 binding not defined\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Provided a mechanistic link in melanosome biogenesis by showing MREG interacts with HPS BLOC-2 members and the Oa1 receptor to control melanosome size, acting from cytoplasmic vesicles rather than melanosomes.\",\n      \"evidence\": \"Genetic epistasis with Mreg knockout/transgenic mice crossed into BLOC-2 mutant and Oa1 knockout backgrounds, transgenic rescue, immunolocalization, and melanosome size quantification\",\n      \"pmids\": [\"22984402\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Biochemical nature and stoichiometry of the BLOC-2 and Oa1 interactions not characterized\", \"Whether interactions are direct unresolved\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Refined the lysosomal role by showing MREG loss enhances secretion of intermediate cathepsin D and disrupts intracellular cathepsin D homeostasis, with concomitant basal laminin accumulation.\",\n      \"evidence\": \"Cathepsin D secretion/activity assays, Western blot for cathepsin D isoforms, and laminin immunostaining in Mreg(dsu/dsu) mouse RPE\",\n      \"pmids\": [\"23611523\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanistic basis for mis-secretion versus retention unclear\", \"Causal relationship to laminin accumulation not established\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Implicated MREG as a regulator of growth signaling by placing it upstream of PI3K/Akt-mTOR, where it suppresses cancer cell invasion and proliferation.\",\n      \"evidence\": \"MREG overexpression and knockdown in thyroid cancer cell lines with phospho-Akt/mTOR Western blots, invasion/proliferation assays, and pharmacological rescue with dactolisib\",\n      \"pmids\": [\"28698135\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular link between MREG and PI3K/Akt-mTOR not defined\", \"Whether this connects to the vesicular trafficking role unknown\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Positioned MREG within a transcriptional/microRNA regulatory axis, showing it is suppressed by E2F1/miR-224-5p and its restoration attenuates migration, invasion and EMT in hepatocellular carcinoma.\",\n      \"evidence\": \"miRNA target validation (TargetScan/miRDB/StarBase), MREG overexpression in HCC cell lines, migration/invasion assays, EMT marker analysis, and rescue experiments\",\n      \"pmids\": [\"35126724\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct luciferase confirmation of binding not specified\", \"Downstream effectors mediating EMT suppression not identified\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The biochemical activity of MREG and how a single small vesicular protein mechanistically couples melanosome biogenesis, lysosomal cathepsin D maturation, and PI3K/Akt-mTOR signaling remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No defined enzymatic or structural mechanism for the protein\", \"No unifying molecular model linking trafficking and growth-signaling roles\", \"Direct versus indirect nature of reported partner interactions not established\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0008289\", \"supporting_discovery_ids\": [5]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0031410\", \"supporting_discovery_ids\": [5, 7]},\n      {\"term_id\": \"GO:0005768\", \"supporting_discovery_ids\": [5]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-9609507\", \"supporting_discovery_ids\": [4, 6]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [9]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"Oa1\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":5,"faith_total":5,"faith_pct":100.0}}